22nd Annual Indy Hematology ReviewTM

Saturday, March 8th 2025 | The Westin Indianapolis

Indy Hematology Review Supporters

2025 Symposium Agenda | Saturday, March 8, 2025

6:00 AM – 10:00 AM Registration
6:45 AM – 7:25 AM Breakfast Product Theater
Session Chair Ruemu E. Birhiray, MD
7:30 AM-8:00 AM State of the Art: 2025: Emerging Therapies in Hematologic Malignancies | Ruemu Birhiray, MD
8:00 AM- 8:40 AM Treatment of Acute Myeloid Leukemias
8:00 AM– 8:20 AM Treatment Options for Newly Diagnosed Patients | Daniel Pollyea, MD, MS
8:20 AM– 8:40 AM Current and Emerging Therapies for Relapsed AML and Myelodysplastic Syndrome | Rami Komrokji, MD
8:40 AM – 9:00 AM Hematopoietic Transplantation and Cellular Therapies: When to Refer | Richard Childs, MD
9:00 AM – 9:20 AM Management of Chronic Myeloid Leukemia in 2025 | Richard Larson, MD
9:20 AM – 9:30 AM Myeloid and Lymphoblastic Leukemias – PANEL DISCUSSION
9:30 AM– 9:45 AM Coffee Break – Exhibit Hall
9:45 AM – 10:05 AM Approaches to the Management of Newly Diagnosed Multiple Myeloma | Saad Z. Usmani, MD, MBA
10:05 AM-10:25 AM Emerging and Current Treatment of Relapsed/Refractory Multiple Myeloma | Kenneth Anderson, MD
10:25 AM -10:45 AM Current Approaches to the Treatment Waldenstrom’s Macroglobulinemia | Steven P. Treon, MD, MA, PhD, FRCP, FACP
10:45 AM-11:05 AM Evaluation, Diagnosis and Treatment of Amyloidosis: Approaches Including and Beyond Anti-CD38 Antibody Therapy | Morie Gertz, MD, MACP
11:05 AM-11:15 AM Plasma Cell Disorders – PANEL DISCUSSION
11:15 AM- 11:25 AM Coffee Break – Exhibit Hall
11:25 AM-11:45 AM Treatment of Complementopathies: Diagnosis and Therapeutic Strategies | Robert A. Brodsky, MD
11:45 AM – 12:05 PM How to treat: Options and Treatment Paradigms for Aplastic Anemia | Neal Young, MD
12:05 PM-12:25 PM Classical Hematology: Managing Disorders of Bleeding and Clotting | Craig Kessler, MD, MACP
12:25 PM – 12:45 PM Treatment Options and Cellular Therapy for Sickle Cell Disease | Matthew Hsieh, MD
12:45 PM-12:55 PM Hematology – PANEL DISCUSSION
1:05 PM – 1:50 PM Luncheon Product Theaters
1:50 PM – 2:00 PM Coffee Break – Exhibit Hall
Session Chair Michael Wiemann, MD, FACP
2:00 PM- 2:45 PM  T. Howard Lee Keynote Lecture: When Not to Watch and Wait: Emerging Strategies in the Treatment of Indolent Lymphoma | Christopher Flowers, MD, MS, FASCO
2:45 PM-3:05 PM Chronic Myelomonocytic leukemia: Diagnosis, Prognostication, and Treatment | Ayalew Tefferi, MD
3:05 PM– 3:25 PM Current and Emerging Treatment Options of Myeloproliferative Neoplasms | Alessandro M. Vannucchi, MD
3:25 PM– 3:30 PM Myeloproliferative Neoplasms – PANEL DISCUSSION
3:30 PM- 3:50 PM How I Choose: Current Approaches to Frontline Treatment of Chronic Lymphocytic Leukemia | Jennifer Woyach, MD
3:50 PM – 4:10 PM Annual Steven Coutre Chronic Lymphocytic Leukemia Memorial Lecture: Emerging and Current Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia | John Byrd, MD, FACP
4:10 PM – 4:20 PM Coffee Break – Exhibit Hall
4:20 PM – 4:40 PM My Approaches to Managing the Controversies in the Treatment of Mantle Cell Lymphomas | Michael Wang, MD, PhD
4:40 PM – 5:00 PM Emerging and Current Treatment for Hodgkin Lymphoma | Stephen M. Ansell, M.D., Ph.D.
5:00 PM – 5:35 PM Current Advances in the treatment of Aggressive B and T Cell Lymphomas | Sonali M. Smith, MD, FASCO
5:35 PM -5:55 PM Bispecific Antibody Therapy for Lymphoid Malignancies | Tycel Phillips, MD
5:55 PM – 6:15 PM Cellular Therapy for Lymphoid Malignancies | Matthew Lunning, DO, FACP
6:15 PM – 6: 35 PM Bispecific and Cellular Therapy for Multiple Myeloma | Joselle Cook, MD
6:35 PM – 7:10 PM The Great IHR 2025 Debate: Controversies in the Treatment of the AYA Patient with Acute Lymphoblastic Leukemia: Pediatric Inspired Chemotherapy Regimens | Richard Stone, MD IO HyperCVAD Inspired Targeted Regimens | Hagop Kantarjian, MD
7:10 PM -7:20 PM Lymphoid Malignancies and Cellular Therapies – PANEL DISCUSSION
7:20 PM – 7:40 PM Reception with Hors D’oeuvres and Beverages
7:40 PM – 8:40 PM Hematologic Malignancies Townhall
Ruemu E. Birhiray, MD – Chair and Moderator
Michael Wiemann, MD, FACP – Co-Chair
Morie Gertz, MD, MACP – Plasma Cell Disorders and Amyloidosis
Jennifer Woyach, MD – Chronic Lymphocytic Leukemia
Richard Stone, MD, IO – Acute Leukemias and Myelodysplastic Syndromes
Christopher Flowers, MD, MS, FASCO – Lymphomas
Saad Usmani, MD, MBA – Multiple Myeloma
Joselle Cook, MD – Multiple Myeloma
Alessandro Vannucchi, MD – Myeloproliferative Neoplasms

Nursing and Allied Providers Symposium Agenda

6:00 – 10:00 AM Registration
6:45 AM – 7:25 AM Breakfast Product Theater
7:30 AM -8:00 AM State of the Art: 2025: Emerging Therapies in Hematologic Malignancies | Ruemu Birhiray, MD
8:10 AM –8:35 AM Understanding and Managing Immune Effector Toxicities in Hematologic Toxicities | David Reeves, PharmD, BCOP
8:35 AM –9:00 AM Management of Long-Term Survivors of Hematologic Malignancies | Sandra Garofalo, MS, APRN, AOCNP
9:00 AM – 9:30 AM Managing Disorders of the Benign Hematology | Craig Kessler, MD, MACP
9:30 AM – 9:45 AM Coffee Break – Exhibit Hall
9:45 AM – 10:15 AM Emerging and Current Treatment of Amyloidosis and Waldenstrom’s Macroglobulinemia | Morie Gertz, MD, MACP
10:15 AM – 10:45 AM Understanding the Diagnosis and Treatment of Plasma Cell Disorders | Joselle Cook, MD
10:45 AM –11:15 AM What I Need Know and Do for My Patient: Evaluating and Managing Toxicities of Cellular and Immune Effector Therapy From a Nursing Perspective | Matthew Lunning, DO, FACP
11:15 AM – 11:30 AM Coffee Break – Exhibit Hall
11:30 AM – 11:55 AM Recognizing Toxicities of Oral Oncolytics in the Management of Hematologic Malignancies | Kristi K Orbaugh RN, MSN, RNP, AOCN
11:55 AM – 12:25 PM Diagnosis and Treatment of Myeloid Leukemias | Rami Komrokji, MD
12:25 PM – 12:55 PM Current and Emerging Therapies for Acute Leukemias and Myelodysplastic Syndromes | Richard Larson, MD
12:55 PM – 1:00 PM Questions and Answers
1:05 PM – 1:50 PM Luncheon Product Theaters
1:50 PM – 2:00 PM Coffee Break – Exhibit Hall
2:00 PM – 2:45 PM T. Howard Lee Keynote Lecture: When Not to Watch and Wait: Emerging Strategies in the Treatment of Indolent Lymphoma | Christopher Flowers, MD, MS, FASCO
3:00 PM – 3:30 PM Tailoring Treatment: The Role of Precision Medicine in Hematology | Christopher Fausel, PharmD, MHA, BCOP
3:30 PM -4:00 PM Bispecific T-Cell Engagers in Multiple Myeloma | Muna Chemali, PharmD, BCOP
4:00 PM – 4:30 PM Clinical Perspectives on Bone Marrow Biopsy: A Nursing Approach | Ellen Rovner, MSN, CNP
4:30 PM – 5:00 PM Comprehensive Hematology Resources: A Social Worker’s Guide to Patient Support | Erin Abney, MSW, LCSW
5:00 PM – 5:30 PM AYA Patients and their Future: Conversations on Sexuality & Fertility | Amanda Saraf, DO
Fellows Agenda